E
13.47
0.05 (0.41%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Mixed | Bearish |
| Drug Manufacturers - Specialty & Generic (Global) | Bearish | Bearish | |
| Stock | Elanco Animal Health Incorporat | - | - |
|
Elanco Animal Health Inc is an animal health company that is engaged in innovating, developing, manufacturing, and marketing products for companion and food animals. Geographically, the company's operations are conducted globally and sell its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production. The company's product portfolio of approximately 200 brands. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Core |
| 52 Weeks Range |
7.88 - 16.88
|
|
| Price Target Range | ||
| High | 19.00 (Barclays, 41.11%) | Overweight |
| Median | 17.50 (29.97%) | |
| Low | 14.00 (Goldman Sachs, 3.97%) | Sell |
| Average | 17.00 (26.25%) | |
| Total | 1 Sell, 2 Overweight, 1 Neutral | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Piper Sandler | 12 Mar 2024 | 18.00 (33.68%) | Neutral | 15.77 |
| Barclays | 27 Feb 2024 | 19.00 (41.11%) | Overweight | 16.46 |
| Goldman Sachs | 27 Feb 2024 | 14.00 (3.97%) | Sell | 16.46 |
| Morgan Stanley | 27 Feb 2024 | 17.00 (26.25%) | Overweight | 16.46 |
No data within this time range.
Show more
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |